Clinical trials
Phase 2 Clostridium Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 5 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 5 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Finch Research and Development LLC. | 2 |
| Rebiotix Inc. | 2 |
| Sanofi Pasteur, a Sanofi Company | 2 |
| Summit Therapeutics | 2 |
| University of Pennsylvania | 2 |
| University of Virginia | 2 |
| University of Wisconsin, Madison | 2 |
| Actelion | 1 |
| Acurx Pharmaceuticals Inc. | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clostridium Infections | 30 |
| Diarrhea | 7 |
| Enterocolitis, Pseudomembranous | 3 |
| Diabetes Insipidus, Neurogenic | 2 |
| Asymptomatic Infections | 1 |
| Bacterial Infections | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
| Hematologic Diseases | 1 |
| Inflammatory Bowel Diseases | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.